Cargando…

Economic burden of illness of acute coronary syndromes: medical and productivity costs

BACKGROUND: The significant economic burden associated with acute coronary syndromes (ACS) provides a need to evaluate both medical costs and productivity costs, according to evolving guideline-driven ACS treatment strategies, medical management (MM), percutaneous coronary intervention (PCI), or cor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhenxiang, Winget, Melissa
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042911/
https://www.ncbi.nlm.nih.gov/pubmed/21314995
http://dx.doi.org/10.1186/1472-6963-11-35
_version_ 1782198572326846464
author Zhao, Zhenxiang
Winget, Melissa
author_facet Zhao, Zhenxiang
Winget, Melissa
author_sort Zhao, Zhenxiang
collection PubMed
description BACKGROUND: The significant economic burden associated with acute coronary syndromes (ACS) provides a need to evaluate both medical costs and productivity costs, according to evolving guideline-driven ACS treatment strategies, medical management (MM), percutaneous coronary intervention (PCI), or coronary artery bypass graft (CABG). METHODS: Commercially insured individuals, aged 18-64, with an emergency room (ER) visit or hospitalization accompanied by an ACS diagnosis (index event) were identified from a large claims database between 01/2004 and 12/2005 with a 1-year follow-up period. Patients who had an ACS diagnosis in the 12 months prior to their index event were excluded. Patients were divided into 3 groups according to treatment strategies during the index event: MM, PCI, or CABG. A subset of patients was identified for the productivity cost analysis exploring short-term disability and absenteeism costs. Multivariate generalized linear models were performed to examine the ACS costs by 3 different treatment strategies. RESULTS: A total of 10,487 patients were identified for the medical cost analysis. The total 1-year medical costs (index event costs plus the 1-year follow-up costs) were lowest for MM patients ($34,087), followed by PCI patients ($52,673) and CABG patients ($86,914). Of the 3,080 patients in the productivity costs analysis, 2,454 patients were identified in the short-term disability cohort and 626 patients were identified in the absenteeism cohort. Both the estimated mean total 1-year short-term disability and absenteeism costs were highest for CABG patients ($17,335, $14,960, respectively) compared to MM patients ($6,048, $9,826, respectively) and PCI patients ($9,221, $9,460, respectively). CONCLUSIONS: Both total 1-year medical costs and 1-year productivity costs are substantial for working-aged individuals with ACS. These costs differ according to the type of treatment strategy, with CABG having higher costs compared to either PCI or MM.
format Text
id pubmed-3042911
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30429112011-02-23 Economic burden of illness of acute coronary syndromes: medical and productivity costs Zhao, Zhenxiang Winget, Melissa BMC Health Serv Res Research Article BACKGROUND: The significant economic burden associated with acute coronary syndromes (ACS) provides a need to evaluate both medical costs and productivity costs, according to evolving guideline-driven ACS treatment strategies, medical management (MM), percutaneous coronary intervention (PCI), or coronary artery bypass graft (CABG). METHODS: Commercially insured individuals, aged 18-64, with an emergency room (ER) visit or hospitalization accompanied by an ACS diagnosis (index event) were identified from a large claims database between 01/2004 and 12/2005 with a 1-year follow-up period. Patients who had an ACS diagnosis in the 12 months prior to their index event were excluded. Patients were divided into 3 groups according to treatment strategies during the index event: MM, PCI, or CABG. A subset of patients was identified for the productivity cost analysis exploring short-term disability and absenteeism costs. Multivariate generalized linear models were performed to examine the ACS costs by 3 different treatment strategies. RESULTS: A total of 10,487 patients were identified for the medical cost analysis. The total 1-year medical costs (index event costs plus the 1-year follow-up costs) were lowest for MM patients ($34,087), followed by PCI patients ($52,673) and CABG patients ($86,914). Of the 3,080 patients in the productivity costs analysis, 2,454 patients were identified in the short-term disability cohort and 626 patients were identified in the absenteeism cohort. Both the estimated mean total 1-year short-term disability and absenteeism costs were highest for CABG patients ($17,335, $14,960, respectively) compared to MM patients ($6,048, $9,826, respectively) and PCI patients ($9,221, $9,460, respectively). CONCLUSIONS: Both total 1-year medical costs and 1-year productivity costs are substantial for working-aged individuals with ACS. These costs differ according to the type of treatment strategy, with CABG having higher costs compared to either PCI or MM. BioMed Central 2011-02-14 /pmc/articles/PMC3042911/ /pubmed/21314995 http://dx.doi.org/10.1186/1472-6963-11-35 Text en Copyright ©2011 Zhao and Winget; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zhao, Zhenxiang
Winget, Melissa
Economic burden of illness of acute coronary syndromes: medical and productivity costs
title Economic burden of illness of acute coronary syndromes: medical and productivity costs
title_full Economic burden of illness of acute coronary syndromes: medical and productivity costs
title_fullStr Economic burden of illness of acute coronary syndromes: medical and productivity costs
title_full_unstemmed Economic burden of illness of acute coronary syndromes: medical and productivity costs
title_short Economic burden of illness of acute coronary syndromes: medical and productivity costs
title_sort economic burden of illness of acute coronary syndromes: medical and productivity costs
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042911/
https://www.ncbi.nlm.nih.gov/pubmed/21314995
http://dx.doi.org/10.1186/1472-6963-11-35
work_keys_str_mv AT zhaozhenxiang economicburdenofillnessofacutecoronarysyndromesmedicalandproductivitycosts
AT wingetmelissa economicburdenofillnessofacutecoronarysyndromesmedicalandproductivitycosts